Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: Short-term and long-term patient outcomes

Archives of Surgery

Volumn 146, Issue 5, 2011, Pages 534-538

  Haynes, Alex B ^a   Deshpande, Vikram ^a   Ingkakul, Thun ^a   Vagefi, Parsia A ^b   Szymonifka, Jackie ^a   Thayer, Sarah P ^a   Ferrone, Cristina R ^a   Wargo, Jennifer A ^a   Warshaw, Andrew L ^a   Castillo, Carlos Fernández Del ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGE; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MITOSIS RATE; MORBIDITY; PANCREAS FISTULA; PANCREAS ISLET CELL CARCINOMA; PANCREAS ISLET CELL TUMOR; PANCREAS SURGERY; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL INFECTION; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INCIDENTAL FINDINGS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TUMOR BURDEN; YOUNG ADULT;

EID: 79956041029     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.102     Document Type: Article

References (16)

1. Vagefi PA, Razo O, Deshpande V, et al. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg. 2007;142(4):347-354.
2. Ferrone CR, Correa-Gallego C, Warshaw AL, et al. Current trends in pancreatic cystic neoplasms. Arch Surg. 2009;144(5):448-454.
3. Modlin IM,Moss SF, Chung DC, Jensen RT, Snyderwine E. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst. 2008;100(18):1282-1289.
4. Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol. 2009;6(7):419-428.
5. Balcom JH IV, Rattner DW,Warshaw AL, Chang Y, Fernandez-del Castillo C. Tenyear experience with733pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136(4):391-398. (Pubitemid 32322810)
6. Heitz PU, Komminoth P, Perrin A, et al. Pancreatic endocrine tumors: introduction. In: DeLellis DA, Lloyd RV, Heitz PU, eds, et al. Pathology and Genetics of Tumours of Endocrine Organs: WHO Classification of Tumours. Lyon, France: International Agency for Research on Cancer Press; 2004:177-182.
7. Mansour JC, Chen H. Pancreatic endocrine tumors. J Surg Res. 2004;120(1):139-161. (Pubitemid 38686540)
8. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934-959. (Pubitemid 36173145)
9. Fitzgerald TL, Hickner ZJ, Schmitz M, Kort EJ. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas. 2008;37(2):134-138.
10. Grimelius L, Hultquist GT, Stenkvist B. Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol. 1975;365(4):275-288.
11. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13-27. (Pubitemid 38594787)
12. Bilimoria KY, Talamonti MS, Tomlinson JS, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008;247(3):490-500.
13. Pape U-F, Jann H, Müller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008;113(2):256-265.
14. Kouvaraki MA, Solorzano CC, Shapiro SE, et al. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol. 2005;89(3):170-185. (Pubitemid 40315914)
15. You DD, Lee HG, Paik KY, Heo JS, Choi SH, Choi DW. The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience. Eur J Surg Oncol. 2009;35(7):728-733.
16. Hill JS, McPhee JT, McDade TP, et al. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer. 2009;115(4):741-751.